Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
04.06.25 | 15:50
122,45 Euro
+0,08 % +0,10
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
121,85123,3512:02
121,85123,3512:02

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoHere's Why You Should Retain ICLR Stock in Your Portfolio Now5
27.05.ICON plc wird auf der jährlichen Growth Stock Konferenz präsentieren3
27.05.ICON plc to Present at the William Blair 45th Annual Growth Stock Conference218ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair...
► Artikel lesen
27.05.ICON PLC - 6-K, Report of foreign issuer4
ICON Aktie jetzt für 0€ handeln
19.05.ICON PLC - 6-K, Report of foreign issuer1
19.05.ICON plc: ICON releases its ICON Cares 2024 Report322ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering...
► Artikel lesen
07.05.ICON plc: Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies235ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across...
► Artikel lesen
30.04.ICON plc: ICON Reports First Quarter 2025 Results493Highlights Net business wins in the quarter of $2,022 million; a net book to bill in the quarter of 1.01. Closing backlog of $24.7 billion, an increase of 0.3% on quarter four 2024 and...
► Artikel lesen
30.04.ICON PLC - 6-K, Report of foreign issuer2
27.04.ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now15
10.04.What Makes Icon PLC (ICLR) an Investment Bet?13
03.04.LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in its Investment Thesis12
31.03.ICON plc Schedules First Quarter 2025 Earnings Conference Call337ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025...
► Artikel lesen
31.03.ICON PLC - 6-K, Report of foreign issuer3
24.03.ICON Public Limited Company (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials4
19.03.ICON Public Limited Company (ICLR) Slid on Disappointing Earnings5
12.03.ICON PLC - 6-K, Report of foreign issuer2
07.03.ICON Public Limited Company (ICLR): A Bull Case Theory4
05.03.ICON plc to Present at Upcoming Investor Conferences280ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink Partners...
► Artikel lesen
04.03.Mural Health, ICON Partner to Enhance Site Experience in Clinical Trials2
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1